High antithrombin III levels attenuate hemostatic activation and leukocyte activation during cardiopulmonary bypass

J Thorac Cardiovasc Surg. 2003 Sep;126(3):906-7. doi: 10.1016/s0022-5223(03)00392-1.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Antithrombin III / administration & dosage*
  • Cardiopulmonary Bypass*
  • Female
  • Hemostasis / drug effects*
  • Humans
  • Intraoperative Period
  • Leukocytes / drug effects*
  • Leukocytes / physiology*
  • Male
  • Middle Aged
  • Prospective Studies
  • Serine Proteinase Inhibitors / administration & dosage*

Substances

  • Serine Proteinase Inhibitors
  • Antithrombin III